We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Stocks in a Bloodbath. Baxter International Inc. (NYSE:BAX) is one of the worst-performing stocks on Thursday. Baxter ...

Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Fintel reports that on August 4, 2025, Stifel downgraded their outlook for Baxter International (NYSE:BAX) from Buy to Hold. Analyst Price Forecast Suggests 72.35% Upside As of July 17, 2025, the ...

Baxter International Inc. ( NYSE: BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather ...

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025.

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Baxter International Inc. BAX is scheduled to release second-quarter 2025 results on July 31, before the opening bell. In the ...